Patents by Inventor Peter Michael Waterhouse

Peter Michael Waterhouse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040231016
    Abstract: Methods and means are provided to increase the efficiency of gene silencing when using dsRNA sequences which have a stem length shorter than about 200 base pairs by providing chimeric genes encoding such dsRNA sequences with a promoter recognized by DNA dependent RNA polymerase III comprising all cis-acting promoter elements which interact with DNA dependent RNA polymerase III.
    Type: Application
    Filed: February 19, 2004
    Publication date: November 18, 2004
    Applicant: Commonwealth Scientific and Industrial Research Organization
    Inventors: Ming Bo Wang, Christopher Andrew Helliwell, Peter Michael Waterhouse
  • Publication number: 20040214330
    Abstract: Methods and means are provided for reducing the phenotypic expression of a nucleic acid of interest in eucaryotic cells, particularly in plant cells, by introducing chimeric genes encoding sense and antisense RNA molecules directed towards the target nucleic acid, which are capable of forming a double stranded RNA region by base-pairing between the regions with sense and antisense nucleotide sequence or by introducing the RNA molecules themselves. Preferably, the RNA molecules comprises simultaneously both sense and antisense nucleotide sequence.
    Type: Application
    Filed: January 13, 2004
    Publication date: October 28, 2004
    Inventors: Peter Michael Waterhouse, Ming-Bo Wang, Michael Wayne Graham
  • Publication number: 20030165894
    Abstract: Methods and means are provided for reducing the phenotypic expression of a nucleic acid of interest in eukaryotic cells, particularly in plant cells, by providing aberrant, preferably unpolyadenylated, target-specific RNA to the nucleus of the host cell. Preferably, the unpolyadenylated target-specific RNA is provided by transcription of a chimeric gene comprising a promoter, a DNA region encoding the target-specific RNA, a self-splicing ribozyme and a DNA region involved in 3′ end formation and polyadenylation.
    Type: Application
    Filed: May 23, 2002
    Publication date: September 4, 2003
    Inventors: Peter Michael Waterhouse, Ming-Bo Wang
  • Patent number: 6492160
    Abstract: Methods, recombinant host cells and kits are disclosed-for the production of members of specific binding pairs (sbp), e.g. antibodies, using display on the surface of secreted replicable genetic display packages (rgdps), e.g. filamentous phage. To produce a library of great diversity recombination occurs between first and second vectors comprising nucleic acid encoding first and second polypeptide chains of sbp members respectively, thereby producing recombinant vectors each encoding both a first and a second polypeptide chain component of a sbp member. The recombination may take place in vitro or intracellularly and may be site-specific, e.g. involving use of the loxP sequence and mutants thereof. Recombination may take place after prior screening or selecting for rgdps displaying sbp members which bind complementary sbp member of interest.
    Type: Grant
    Filed: June 25, 1998
    Date of Patent: December 10, 2002
    Assignees: Cambridge Antibody Technology Limited, Medical Research Council
    Inventors: Andrew David Griffiths, Samuel Cameron Williams, Peter Michael Waterhouse, Ahuva Nissim, Gregory Paul Winter, Kevin Stuart Johnson, Andrew John Hammond Smith
  • Publication number: 20020147168
    Abstract: The present invention is directed to the genetic transformation using multiple genetic sequences, wherein one of said genetic sequences encodes a polypeptide possessing excision activity, specifically a site-specific recombinase activity linked to a transgene unit and the use of this genetic construct in the removal of transgenes therefrom. The present invention provides the means to produce genetically-transformed organisms, in particular plants, in which selectable marker genes have been removed, thereby facilitating multiple sequential genetic transformation events using the same selectable marker gene. Accordingly, the invention provides the means for regulating transgene expression in genetically-manipulated organisms, for example to promote differentiation, de-differentiation, or any unidirectional developmental shift of a target cell which requires the time-specific expression of a particular gene.
    Type: Application
    Filed: May 7, 2001
    Publication date: October 10, 2002
    Inventors: Brian Peter Surin, Robert Charles De Feyter, Michael Wayne Graham, Peter Michael Waterhouse, Paul Konrad Keese, Shahjahan Ali
  • Patent number: 6423885
    Abstract: Methods are provided for reducing the phenotypic expression of a nucleic acid of interest in plant cells, by providing aberrant, preferably unpolyadenylated, target-specific RNA to the nucleus of the host cell. Preferably, the unpolyadenylated target-specific RNA is provided by transcription of a chimeric gene comprising a promoter, a DNA region encoding the target-specific RNA, a self-splicing ribozyme and a DNA region involved in 3′ end formation and polyadenylation.
    Type: Grant
    Filed: August 13, 1999
    Date of Patent: July 23, 2002
    Assignee: Commonwealth Scientific and Industrial Research Organization (CSIRO)
    Inventors: Peter Michael Waterhouse, Ming-Bo Wang
  • Patent number: 6211431
    Abstract: The present invention is directed to transcription regulators and transcription regulator-like sequences of nanovirus origin. As used in the specification, the nanovirus group is consdiered to include subterranean clover stunt virus (SCSV), cocnut foliar decay virus (CFDV), banana bunchy top virus (BBTV), milk vetch dwarf cirus (MDV), and faba bean necrotic yellow virus (FBNYV). The transcription regulators and transcription regulator-like sequences of the instant invention are useful in genetic engineering of plants and in particular leguminous plants such as to facilitate or control expression of foreign genes. The transcription regulators and transcription regulator-like sequences of the present invention are also useful in facilitating different levels of expression in different plant tissue types.
    Type: Grant
    Filed: June 9, 1997
    Date of Patent: April 3, 2001
    Assignee: Commonwealth Scientific and Industrial Research Organization
    Inventors: Petra Christina Boevink, Brian Peter Surin, Paul Konrad Keese, Paul Wing Gay Chu, Peter Michael Waterhouse, Rafiqul Islam Khan, Philip John Larkin, William Clark Taylor, Jerry Stuart Marshall
  • Patent number: 6140471
    Abstract: Methods, recombinant host cells and kits are disclosed for the production of members of specific binding pairs (sbp), e.g. antibodies, using display on the surface of secreted replicable genetic display packages (rgdps), e.g. filamentous phage. To produce a library of great diversity, recombination occurs between first and second vectors comprising nucleic acid encoding first and second polypeptide chains of sbp members respectively, thereby producing recombinant vectors each encoding both a first and a second polypeptide chain component of an sbp member. The recombination may take place in vitro or intracellularly and may be site-specific, e.g. involving use of the loxP sequence and mutants thereof. Recombination may take place after prior screening or selecting for rgdps displaying sbp members which bind complementary sbp member of interest.
    Type: Grant
    Filed: March 30, 1998
    Date of Patent: October 31, 2000
    Assignees: Cambridge Antibody Technology, Ltd., Medical Research Council
    Inventors: Kevin Stuart Johnson, Gregory Paul Winter, Andrew David Griffiths, Andrew John Hammond Smith, Peter Michael Waterhouse
  • Patent number: 5962255
    Abstract: Methods, recombinant host cells and kits are disclosed for the production of members of specific binding pairs (sbp), e.g. antibodies, using display on the surface of secreted replicable genetic display packages (rgdps), e.g. filamentous phage. To produce a library of great diversity recombination occurs between first and second vectors comprising nucleic acid encoding first and second polypeptide chains of sbp members respectively, thereby producing recombinant vectors each encoding both a first and a second polypeptide chain component of a sbp member. The recombination may take place in vitro or intracellularly and may be site-specific, e.g. involving use of the loxP sequence and mutants thereof. Recombination may take place after prior screening or selecting for rgdps displaying sbp members which bind complementary sbp member of interest.
    Type: Grant
    Filed: December 5, 1994
    Date of Patent: October 5, 1999
    Assignees: Cambridge Antibody Technology Limited, Medical Research Council
    Inventors: Andrew David Griffiths, Samuel Cameron Williams, Peter Michael Waterhouse, Ahuva Nissim, Gregory Paul Winter, Kevin Stuart Johnson, Andrew John Hammond Smith
  • Patent number: 5733743
    Abstract: Methods, recombinant host cells and kits are disclosed for the production of members of specific binding pairs (sbp), e.g. antibodies, using display on the surface of secreted replicable genetic display packages (rgdps), e.g. filamentous phage. To produce a library of great diversity, recombination occurs between first and second vectors comprising nucleic acid encoding first and second polypeptide chains of sbp members respectively, thereby producing recombinant vectors each encoding both a first and a second polypeptide chain component of an sbp member. The recombination may take place in vitro or intracellularly and may be site-specific, e.g. involving use of the loxP sequence and mutants thereof. Recombination may take place after prior screening or selecting for rgdps displaying sbp members which bind complementary sbp member of interest.
    Type: Grant
    Filed: November 18, 1994
    Date of Patent: March 31, 1998
    Assignees: Cambridge Antibody Technology Limited, Medical Research Council
    Inventors: Kevin Stuart Johnson, Gregory Paul Winter, Andrew David Griffiths, Andrew John Hammond Smith, Peter Michael Waterhouse